Drug Shortage Report for APO TRIAZIDE
| Report ID | 127762 |
| Drug Identification Number | 00441775 |
| Brand name | APO TRIAZIDE |
| Common or Proper name | TRIAZIDE |
| Company Name | APOTEX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | TRIAMTERENE HYDROCHLOROTHIAZIDE |
| Strength(s) | 50MG 25MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 1000 BTL |
| ATC code | C03EA |
| ATC description | DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-11-02 |
| Estimated end date | 2021-01-08 |
| Actual end date | 2020-12-30 |
| Shortage status | Resolved |
| Updated date | 2020-12-31 |
| Company comments | |
| Health Canada comments | |
| Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
| Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.